Search Within

Dan Douer

Formats
  1. Journal Article (45)
  2. Meeting Abstract (41)
  3. Book Section (1)
Groups
  1. Department of Medicine (87)
  2. Hematologic Malignancies, Division of (87)
  3. Center for Hematologic Malignancies (60)
  4. Adult Leukemia (58)
  5. Biostatistics Service (20)
  6. Epidemiology and Biostatistics (20)

More Groups

People
  1. Martin Tallman (50)
  2. Jae Park (29)
  3. Sean Devlin (16)
  4. Peter Maslak (9)
  5. Ross Levine (9)
  6. Eytan Stein (7)

More People

Years
  1. 2021 (2)
  2. 2020 (1)
  3. 2018 (4)
  4. 2017 (3)
  5. 2016 (16)
  6. 2015 (15)

More Years

Publications
  1. Blood (38)
  2. Leukemia Research (7)
  3. Journal of Clinical Oncology (6)
  4. Acta Haematologica (4)
  5. Clinical Advances in Hematology & Oncology (4)
  6. Best Practice and Research: Clinical Haematology (3)

More Publications

Publishers
  1. American Society of Hematology (39)
  2. Elsevier Ltd (7)
  3. American Society of Clinical Oncology (6)
  4. Elsevier Inc. (6)
  5. Millennium Medical Publishing, Inc (4)
  6. S. Karger AG (4)

More Publishers

Results (87)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Will novel agents for ALL finally change the natural history?
    Journal Article

    Douer, D.
    Best Practice and Research: Clinical Haematology (2014)

    Fulltext@MSK | Save
  • Acute lymphoblastic leukemia in adolescents and young adults
    Journal Article

    Burke, P. W.; Douer, D.
    Acta Haematologica (2014)

    Fulltext@MSK | Save
  • Leukemias and myelodysplastic syndromes
    Book Section

    Watts, J. M.; Klimek, V. M.; Tallman, M. S.; Douer, D.; Olson, A. L.; Berman, E.; Intlekofer, A. M.; Zelenetz, A. D.
    In Drilon, A. E.; Postow, M. A.; Krug, L. M. (Eds.) Pocket Oncology (2014)

    Fulltext@MSK | Save
  • Adding ascorbic acid to arsenic trioxide produces limited benefit in patients with acute myeloid leukemia excluding acute promyelocytic leukemia
    Journal Article

    Aldoss, I.; Mark, L.; Vrona, J.; Ramezani, L.; Weitz, I.; Mohrbacher, A. M.; Douer, D.
    Annals of Hematology (2014)

    Fulltext@MSK | Save
  • Younger adults with acute myeloid leukemia in remission for ≥3 years have a high likelihood of cure: The ECOG experience in over 1200 patients
    Journal Article

    Watts, J. M.; Wang, X. V.; Litzow, M. R.; Luger, S. M.; Lazarus, H. M.; Cassileth, P. A.; Fernandez, H. F.; Douer, D.; Zickl, L.; Paietta, E.; more...
    Leukemia Research (2014)

    Fulltext@MSK | Save
  • Extramedullary disease in APL: A real phenomenon to contend with or not?
    Journal Article

    Ganzel, C.; Douer, D.
    Best Practice and Research: Clinical Haematology (2014)

    Fulltext@MSK | Save
  • Pharmacokinetics-based integration of multiple doses of intravenous pegaspargase in a pediatric regimen for adults with newly diagnosed acute lymphoblastic leukemia
    Journal Article

    Douer, D.; Aldoss, I.; Lunning, M. A.; Burke, P. W.; Ramezani, L.; Mark, L.; Vrona, J.; Park, J. H.; Tallman, M. S.; Avramis, V. I.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Efficacy and toxicity management of 19-28z CAR T cell therapy in B cell acute lymphoblastic leukemia
    Journal Article

    Davila, M. L.; Riviere, I.; Wang, X.; Bartido, S.; Park, J.; Curran, K.; Chung, S. S.; Stefanski, J.; Borquez-Ojeda, O.; Olszewska, M.; more...
    Science Translational Medicine (2014)

    Fulltext@MSK | Save
  • A high complete remission rate can be achieved in older patients (age >= 60) with acute lymphoblastic leukemia regardless of induction intensities: Single-institution experience at Memorial Sloan-Kettering Cancer Center
    Meeting Abstract

    Park, J. H.; Lee, S.; Devlin, S. M.; Tallman, M. S.; Douer, D.
    Blood (2013)

    Fulltext@MSK | Save
  • The number of peg-asparaginase doses administered is a determinant of relapse risk in adult ALL treated with a pediatric-like regimen
    Meeting Abstract

    Aldoss, I.; Pullarkat, V.; Martinez, D.; Ji, L.; Douer, D.
    Blood (2013)

    Fulltext@MSK | Save